MainBoardListed
Senores Pharmaceuticals Limited
Company websiteSize: ₹1,48,87,723 crore. Fresh issue: ₹1,27,87,723 crore. OFS: ₹21,00,000 crore.
When to apply: 20-12-2024 — 24-12-2024. Allotment: 26-12-2024. Listing: 30-12-2024. Note: OFS does not raise fresh capital for the company.
Start Date20-12-2024
End Date24-12-2024
Listing Date30-12-2024
Allotment Date26-12-2024
Current Price₹600
GMP₹284 (72.63%)
Lot Size38 Shares
Subscription97.25 Times
Face Value₹10 per share
Listing atNSE, BSE
Issue Price₹372 - ₹391
Pre Issue₹3,32,65,865
Post Issue₹4,60,53,588
Issue Size₹1,48,87,723
(aggregating up to 582.11 Cr)
(aggregating up to 582.11 Cr)
Fresh Issue₹1,27,87,723
(aggregating up to 500.00 Cr)
(aggregating up to 500.00 Cr)
Offer For Sale₹21,00,000
(aggregating up to 82.11 Cr)
(aggregating up to 82.11 Cr)
The Grey Market Premium (GMP) for Senores Pharmaceuticals Limited is currently around ₹284 (72.63%). This indicates an estimated listing price of approximately ₹656 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
14 Nov 2025, 06:51 | ₹391 | ₹284 | ₹675 (72.63%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Senores Pharmaceuticals Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
EPS | 7.20 | 13.67 | 8.87 |
ROE | 8.69 | 23.60 | 20.55 |
ROCE | 7.59 | 11.73 | 18.56 |
RONW | 8.69 | 23.60 | 20.55 |
PRE IPO | 0 | 39.77 | 0 |
POST IPO | 28.21 | 0 | 0 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
HNIs (10L+) | 2,644 | 53,198 | 20.12 |
HNIs(2-10L) | 1,322 | 1,42,233 | 107.59 |
Retail | 38,982 | 30,76,031 | 78.91 |
Employee | 0 | 29,405 | 0.00 |
Total | 42,948 | 32,71,462 | 76.17 |
The IPO reservation for Senores Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 54.05% | 44,43,818 |
HNI | 27.02% | 22,21,909 |
RETAIL | 18.02% | 14,81,272 |
Employee | 0.91% | 75,000 |
TOTAL | 100.00% | 82,21,999 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail | 1 | 38 | ₹14,858 | |
sHNI | 14 | 532 | ₹2,08,012 | |
bHNI | 68 | 2,584 | ₹10,10,344 |
Below you can find the official contact details of Senores Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@senorespharma.com
Phone: +91-79-29999857
Website: https://senorespharma.com/
Address: 1101 to 1103, 11th floor,, South Tower, ONE 42 oppositeJayantilal Park, Ambali Bopal Road, Ahmedabad,-380054
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91 8108114949